| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5785053 | BAYER HLTHCARE | Inserter for the positioning of an intrauterine device |
Dec, 2015
(8 years ago) | |
| US10561524 | BAYER HLTHCARE | Inserter |
Sep, 2029
(5 years from now) | |
| US9615965 | BAYER HLTHCARE | Inserter |
Sep, 2029
(5 years from now) | |
| US10987244 | BAYER HLTHCARE | Inserter |
Apr, 2031
(6 years from now) | |
| US9668912 | BAYER HLTHCARE | Inserter |
Apr, 2031
(6 years from now) | |
Mirena is owned by Bayer Hlthcare.
Mirena contains Levonorgestrel.
Mirena has a total of 5 drug patents out of which 1 drug patent has expired.
Expired drug patents of Mirena are:
- US5785053
Mirena was authorised for market use on 06 December, 2000.
Mirena is available in intrauterine device;intrauterine dosage forms.
Mirena can be used as a method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to release the intrauterine system, a method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the handle to release the ius into the uterus.
The generics of Mirena are possible to be released after 01 April, 2031.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Dosing Schedule(D-181) | Aug 20, 2023 |
| New Indication(I-610) | Oct 01, 2012 |
Drugs and Companies using LEVONORGESTREL ingredient
Market Authorisation Date: 06 December, 2000
Treatment: A method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the h...
Dosage: INTRAUTERINE DEVICE;INTRAUTERINE
MIRENA family patents
